Wilmington Savings Fund Society FSB Buys New Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Wilmington Savings Fund Society FSB acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 10,425 shares of the medical device company's stock, valued at approximately $1,150,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Innealta Capital LLC bought a new stake in shares of Cooper Companies in the second quarter worth $25,000. Ashton Thomas Securities LLC bought a new stake in Cooper Companies during the third quarter worth $25,000. Crewe Advisors LLC raised its position in Cooper Companies by 286.4% during the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company's stock worth $30,000 after acquiring an additional 252 shares in the last quarter. Tortoise Investment Management LLC raised its position in Cooper Companies by 75.4% during the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company's stock worth $34,000 after acquiring an additional 169 shares in the last quarter. Finally, Covestor Ltd raised its position in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company's stock worth $37,000 after acquiring an additional 200 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 2.00% of the stock is currently owned by company insiders.

Cooper Companies Trading Down 1.9 %

COO stock traded down $1.87 on Friday, reaching $94.85. The company's stock had a trading volume of 1,779,826 shares, compared to its average volume of 1,163,765. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38. The firm has a market cap of $18.93 billion, a PE ratio of 48.64, a PEG ratio of 2.52 and a beta of 0.97. The business has a fifty day simple moving average of $103.49 and a two-hundred day simple moving average of $98.92. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts' consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm's revenue was up 9.8% compared to the same quarter last year. During the same period last year, the business posted $0.87 earnings per share. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on COO shares. Stifel Nicolaus reiterated a "buy" rating and issued a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Robert W. Baird upped their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the company an "outperform" rating in a research note on Thursday, August 29th. Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Friday, December 6th. Citigroup reduced their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a research note on Friday, December 6th. Finally, Piper Sandler raised their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the company an "overweight" rating in a research note on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.